デフォルト表紙
市場調査レポート
商品コード
1692396

心血管情報システム市場- 世界の産業規模、シェア、動向、機会、予測、運用形態別(ウェブベース、クラウドベース、オンサイト)、システム別(CVIS、CPACS)、地域別、競合別セグメント、2020-2030F

Cardiovascular Information System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Mode of Operation (Web based, Cloud based, On site), By System (CVIS, CPACS), By Region & Competition, 2020-2030F


出版日
ページ情報
英文 180 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

心血管情報システム市場- 世界の産業規模、シェア、動向、機会、予測、運用形態別(ウェブベース、クラウドベース、オンサイト)、システム別(CVIS、CPACS)、地域別、競合別セグメント、2020-2030F
出版日: 2025年03月24日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心血管情報システムの世界市場規模は2024年に12億5,000万米ドル、予測期間中のCAGRは9.37%で、2030年には21億4,000万米ドルに達すると予測されています。

心血管情報システム(CVIS)の世界市場とは、循環器ヘルスケア分野における情報システムや技術ソリューションの開発、導入、活用を中心に展開される業界を指します。これらのシステムは、心臓・血管疾患に関連する患者データ、画像診断、臨床ワークフローの管理を合理化・改善するために設計されています。2019年に発表された世界保健機関(WHO)の報告書によると、全世界の死亡者数の32%にあたる1,790万人が心血管疾患に起因しています。このうち85%は心臓発作または脳卒中が死因でした。

市場概要
予測期間 2026-2030
市場規模:2024年 12億5,000万米ドル
市場規模:2030年 21億4,000万米ドル
CAGR:2025年~2030年 9.37%
急成長セグメント ウェブベース
最大市場 北米

市場促進要因

心血管疾患の増加

主な市場課題

相互運用性の問題

主な市場動向

クラウドベースのCVISソリューション

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の心血管情報システム市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 運用モード別(Webベース、クラウドベース、オンサイト)
    • システム別(CVIS、CPACS)
    • 地域別
    • 企業別(2024)
  • 製品市場マップ
    • 運用モード別
    • システム別
    • 地域別

第6章 北米の心血管情報システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米:国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の心血管情報システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州:国別分析
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン

第8章 アジア太平洋地域の心血管情報システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域:国別分析
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国

第9章 南米の心血管情報システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの心血管情報システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Koninklijke Philips N.V.
  • GE HealthCare
  • Cisco Systems Inc
  • FUJIFILM Medical Systems USA Inc
  • Siemens Healthcare GmbH
  • Cerner Corp
  • Lumedx Corp
  • Digisonics Inc
  • Honeywell International Inc
  • McKesson Corporation

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 20750

Global Cardiovascular Information System Market was valued at USD 1.25 billion in 2024 and is expected to reach USD 2.14 billion by 2030 with a CAGR of 9.37% during the forecast period. The Global Cardiovascular Information System (CVIS) Market refers to the industry that revolves around the development, implementation, and utilization of information systems and technology solutions in the field of cardiovascular healthcare. These systems are designed to streamline and improve the management of patient data, diagnostic imaging, and clinical workflows related to heart and vascular diseases. According to a World Health Organization (WHO) report published in 2019, 17.9 million deaths, or 32% of all fatalities worldwide, were attributed to cardiovascular diseases. In 85% of these cases, a heart attack or stroke was the cause of death.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.25 Billion
Market Size 2030USD 2.14 Billion
CAGR 2025-20309.37%
Fastest Growing SegmentWeb-based
Largest MarketNorth America

Key Market Drivers

Rising Cardiovascular Disease Burden

Cardiovascular diseases, including heart conditions and vascular ailments, continue to cast a long shadow on global public health. These conditions are the leading cause of mortality worldwide, posing a significant burden on healthcare systems, economies, and, most importantly, the lives of countless individuals. In the face of this growing cardiovascular disease burden, the Global Cardiovascular Information System (CVIS) market is experiencing a substantial boost.

Cardiovascular diseases are a global health epidemic, affecting people across all continents and income groups. These conditions encompass a wide range of disorders, including coronary artery disease, heart failure, stroke, and peripheral vascular disease. The World Health Organization (WHO) cardiovascular diseases representing 32% of all global deaths. The escalating prevalence of these diseases is the primary driver behind the growing demand for CVIS solutions. As populations age, adopt sedentary lifestyles, and experience an increase in risk factors such as hypertension and diabetes, the number of cardiovascular patients is on the rise. Consequently, healthcare systems worldwide are searching for innovative tools and technologies to manage this influx efficiently.

According to WHO, Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions. More than four out of five CVD deaths are due to heart attacks and strokes, and one third of these deaths occur prematurely in people under 70 years of age.

Key Market Challenges

Interoperability Issues

Interoperability is a significant challenge within the healthcare industry. CVIS systems need to seamlessly integrate with various healthcare IT systems, including electronic health records (EHRs), diagnostic imaging systems, and telemedicine platforms. Achieving seamless data exchange between different systems and vendors can be complex, requiring the use of standardized protocols and robust data sharing solutions.

Key Market Trends

Cloud-Based CVIS Solutions

Cloud-based CVIS solutions are gaining traction due to their scalability, flexibility, and cost-effectiveness. Storing cardiovascular patient data and diagnostic images in the cloud allows for easy access from multiple locations, enhancing collaborative care and remote consultations. It also minimizes the need for extensive on-site hardware infrastructure, reducing the financial burden on healthcare institutions.

Key Market Players

  • Koninklijke Philips N.V.
  • GE HealthCare
  • Cisco Systems Inc
  • FUJIFILM Medical Systems USA Inc
  • Siemens Healthcare GmbH
  • Cerner Corp
  • Lumedx Corp
  • Digisonics Inc
  • Honeywell International Inc
  • McKesson Corporation

Report Scope:

In this report, the Global Cardiovascular Information System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiovascular Information System Market, By Mode of Operation:

  • Web based
  • Cloud based
  • On site

Cardiovascular Information System Market, By System:

  • CVIS
  • CPACS

Cardiovascular Information System Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiovascular Information System Market.

Available Customizations:

Global Cardiovascular Information System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiovascular Information System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Mode of Operation (Web based, Cloud based, On site)
    • 5.2.2. By System (CVIS, CPACS)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Mode of Operation
    • 5.3.2. By System
    • 5.3.3. By Region

6. North America Cardiovascular Information System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Mode of Operation (Web based, Cloud based, On site)
    • 6.2.2. By System (CVIS, CPACS)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cardiovascular Information System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Mode of Operation
        • 6.3.1.2.2. By System
    • 6.3.2. Canada Cardiovascular Information System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Mode of Operation
        • 6.3.2.2.2. By System
    • 6.3.3. Mexico Cardiovascular Information System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Mode of Operation
        • 6.3.3.2.2. By System

7. Europe Cardiovascular Information System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Mode of Operation (Web based, Cloud based, On site)
    • 7.2.2. By System (CVIS, CPACS)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cardiovascular Information System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Mode of Operation
        • 7.3.1.2.2. By System
    • 7.3.2. United Kingdom Cardiovascular Information System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Mode of Operation
        • 7.3.2.2.2. By System
    • 7.3.3. France Cardiovascular Information System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Mode of Operation
        • 7.3.3.2.2. By System
    • 7.3.4. Italy Cardiovascular Information System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Mode of Operation
        • 7.3.4.2.2. By System
    • 7.3.5. Spain Cardiovascular Information System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Mode of Operation
        • 7.3.5.2.2. By System

8. Asia-Pacific Cardiovascular Information System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Mode of Operation (Web based, Cloud based, On site)
    • 8.2.2. By System (CVIS, CPACS)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Cardiovascular Information System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Mode of Operation
        • 8.3.1.2.2. By System
    • 8.3.2. Japan Cardiovascular Information System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Mode of Operation
        • 8.3.2.2.2. By System
    • 8.3.3. India Cardiovascular Information System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Mode of Operation
        • 8.3.3.2.2. By System
    • 8.3.4. Australia Cardiovascular Information System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Mode of Operation
        • 8.3.4.2.2. By System
    • 8.3.5. South Korea Cardiovascular Information System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Mode of Operation
        • 8.3.5.2.2. By System

9. South America Cardiovascular Information System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Mode of Operation (Web based, Cloud based, On site)
    • 9.2.2. By System (CVIS, CPACS)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cardiovascular Information System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Mode of Operation
        • 9.3.1.2.2. By System
    • 9.3.2. Argentina Cardiovascular Information System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Mode of Operation
        • 9.3.2.2.2. By System
    • 9.3.3. Colombia Cardiovascular Information System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Mode of Operation
        • 9.3.3.2.2. By System

10. Middle East and Africa Cardiovascular Information System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Mode of Operation (Web based, Cloud based, On site)
    • 10.2.2. By System (CVIS, CPACS)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cardiovascular Information System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Mode of Operation
        • 10.3.1.2.2. By System
    • 10.3.2. Saudi Arabia Cardiovascular Information System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Mode of Operation
        • 10.3.2.2.2. By System
    • 10.3.3. UAE Cardiovascular Information System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Mode of Operation
        • 10.3.3.2.2. By System
    • 10.3.4. Kuwait Cardiovascular Information System Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Mode of Operation
        • 10.3.4.2.2. By System

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Koninklijke Philips N.V.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Product Offerings
    • 14.1.4. Recent Developments
    • 14.1.5. Financials (As Reported)
    • 14.1.6. Key Personnel
    • 14.1.7. SWOT Analysis
  • 14.2. GE HealthCare
  • 14.3. Cisco Systems Inc
  • 14.4. FUJIFILM Medical Systems USA Inc
  • 14.5. Siemens Healthcare GmbH
  • 14.6. Cerner Corp
  • 14.7. Lumedx Corp
  • 14.8. Digisonics Inc
  • 14.9. Honeywell International Inc
  • 14.10. McKesson Corporation

15. Strategic Recommendations

16. About Us & Disclaimer